DuLac Farmaceutici, an Italian wellness company rooted in pharmaceutical expertise, has announced plans to expand its presence in the United States following continued growth through its Amazon U.S. storefront. The expansion strategy targets additional retail, e-commerce, wellness, and recovery-focused distribution channels in the coming months.
Founded on more than 30 years of pharmaceutical industry experience, DuLac Farmaceutici has built a reputation in Europe for combining traditional botanical ingredients with advanced manufacturing technologies and pharmacy-first production standards. The company’s growing U.S. presence reflects increasing consumer demand for wellness and recovery products developed with pharmaceutical-grade precision, clean-label formulations, and ingredient traceability.
“At DuLac, our mission has always been to develop innovative and effective wellness solutions rooted in both science and nature,” said Gabriele Bollani, Founder and CEO of DuLac Farmaceutici. “We are excited to continue expanding our presence in the United States and introduce more consumers to products developed through decades of Italian pharmaceutical expertise, advanced research, and high-quality manufacturing standards.”
DuLac’s portfolio includes recovery-focused dermocosmetic products, wellness solutions, and circulation-support formulations designed for active lifestyles, everyday comfort, and wellness-conscious consumers. The company’s product lineup includes its Arnica Gel 98% collection, Arnica Gel 98% Formula Complex recovery products, and vascular and microcirculation wellness solutions including Diosmin 500 and Dinaven.
For its Arnica Gel 98% formulations, DuLac utilizes a vertically integrated “seed-to-shelf” production model designed to support phytocomplex consistency, traceability, and quality control across cultivation, extraction, formulation, and manufacturing. For selected botanical formulations, the company employs advanced technologies including supercritical CO₂ extraction and controlled-environment cultivation systems designed to help preserve botanical integrity and consistency.
DuLac recently partnered with a state-of-the-art 2,500-square-meter research and manufacturing hub in Italy that combines AI-assisted formulation technology with pharmaceutical-grade production standards. The facility operates under GMP, ISO 22716, and ISO 9001 quality frameworks and supports the company’s growing international expansion efforts.
“Our goal is not simply to sell wellness products, but to elevate standards across the category,” added Bollani. “By combining pharmaceutical expertise, modern innovation, and carefully selected natural ingredients, we are building solutions designed around real consumer wellness needs.”
As part of its broader U.S. growth strategy, DuLac plans to expand awareness across additional retail, e-commerce, wellness, and recovery-focused distribution channels. Consumers can explore DuLac Farmaceutici products through the company’s official U.S. Amazon storefront.
